VICA — Omed Share Price
Last trade - 00:00- $0.00m
- $0.08m
- $0.41m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -1241.65% | ||
Financial Summary
| Year End 31st Dec | Unit | 2014 | 2015 | 2016 | 2017 | 2018 | 2019E | 2020E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.03 | 0.06 | 0.69 | 0.36 | 0.41 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Omed, Inc., formerly Optecmed, Inc., is focused on disruptive technologies in the fields of digital health, prosthetics, orthotics, diabetes, assistive devices, sports and wellbeing, and deep vein thrombosis (DVT). It has developed sensing technology under the brand name Flexisense, which uses a multitude of micro sensors to detect pressure as well as shear. It is also focusing on the fields of prosthetics and orthotics (P&O) and diabetic foot clinics in Europe. It holds a wholesale license for medicinal products for human use through C-Pharm, Ltd. It trades pharmaceutical products to wholesalers and manufacturers around the world. It also supplies medical consumables to cruise ships and merchant vessels. Its subsidiaries include C-Pharm, Ltd., HCi Viocare Technologies Limited and HCi Viocare Clinics UK Limited. Its HCi Viocare Technologies is developing hardware solutions focusing on providing on demand information in the fields of digital health, prosthetics, orthotics and DVT.
Directors
- Constantinos Zertalis CHM (41)
- Paraskevi Pylarinou CFO (30)
- Georgios Thrapsaniotis TRS (73)
- Yannis Levantis DRC
- Last Annual
- December 31st, 2018
- Last Interim
- March 31st, 2019
- Incorporated
- March 26th, 2007
- Public Since
- October 6th, 2008
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 122,022,796
- Address
- Kintyre House, 209 Govan Road, GLASGOW, G51 1HJ
- Web
- Phone
- +44 1413700321
- Auditors
- Heaton & Company PLLC
Upcoming Events for VICA
Similar to VICA
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 22:51 UTC, shares in Omed are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Omed last closed at $0.00 and the price had moved by -99.75% over the past 365 days. In terms of relative price strength the Omed share price has underperformed the S&P500 Index by -99.81% over the past year.
There is no consensus recommendation for this security.
Find out moreOmed does not currently pay a dividend.
Omed does not currently pay a dividend.
Omed does not currently pay a dividend.
To buy shares in Omed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Omed had a market capitalisation of $0.00m.
Here are the trading details for Omed:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: VICA
Based on an overall assessment of its quality, value and momentum Omed is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Omed. Over the past six months, its share price has underperformed the S&P500 Index by -7.94%.
As of the last closing price of $0.00, shares in Omed were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Omed PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Omed's management team is headed by:
- Constantinos Zertalis - CHM
- Paraskevi Pylarinou - CFO
- Georgios Thrapsaniotis - TRS
- Yannis Levantis - DRC